Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor

The present invention concerns a pharmaceutical composition where a checkpoint inhibitor is combined with an oncolytic virus and the use of said combination for the treatment of cancer.

Saved in:
Bibliographic Details
Main Authors Leuchs, Barbara, Angelova, Assia, Dahm, Michael, Marchini, Antonio, Jager, Dirk, Rommelaere, Jean, Wick, Wolfgang
Format Patent
LanguageEnglish
Published 23.04.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention concerns a pharmaceutical composition where a checkpoint inhibitor is combined with an oncolytic virus and the use of said combination for the treatment of cancer.
Bibliography:Application Number: US202117226199